AIM
AVNS icon

Alambic Investment Management’s Avanos Medical AVNS Stock Holding History

Alambic Investment Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-25,050
Closed -$1.16M – 464
2017
Q4 		$1.16M Sell
25,050
-5,700
-19% -$262K 0.14% 235
2017
Q3 		$1.39M Sell
30,750
-1,950
-6% -$83.2K 0.15% 216
2017
Q2 		$1.28M Sell
32,700
-4,100
-11% -$155K 0.16% 221
2017
Q1 		$1.4M Buy
36,800
+13,400
+57% +$522K 0.17% 194
2016
Q4 		$865K Buy
23,400
+2,400
+11% +$85.8K 0.15% 221
2016
Q3 		$728K Sell
21,000
-400
-2% -$14K 0.17% 208
2016
Q2 		$696K Buy
21,400
+10,700
+100% +$328K 0.17% 214
2016
Q1 		$307K Buy
+10,700
New +$285K 0.1% 316

Other funds holding AVNS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return